FMP

FMP

Enter

OPNT - Opiant Pharmaceuticals, Inc.

Profile of Opiant Pharmaceuticals, Inc.(OPNT), Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions

About

ceo

Dr. Roger Crystal M.D.

sector

Healthcare

industry

Biotechnology

website

https://www.opiant.com

exchange

NASDAQ

Description

Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.

CIK

0001385508

ISIN

US6837501039

CUSIP

683750103

Address

233 Wilshirre Boulevard

Phone

310 598 5410

Country

US

Employee

37

IPO Date

Jun 4, 2007

Key Executives

page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep